2/9
08:01 am
cldx
Celldex to Present at Upcoming Investor Conferences
Medium
Report
Celldex to Present at Upcoming Investor Conferences
1/28
08:27 pm
cldx
A Look At Celldex Therapeutics (CLDX) Valuation After Recent Weak Trading Performance [Yahoo! Finance]
Low
Report
A Look At Celldex Therapeutics (CLDX) Valuation After Recent Weak Trading Performance [Yahoo! Finance]
1/13
04:15 pm
cldx
MoneyShow's Best Investment Ideas For 2026: Part 3 [Seeking Alpha]
Low
Report
MoneyShow's Best Investment Ideas For 2026: Part 3 [Seeking Alpha]
1/12
10:57 am
cldx
Celldex Therapeutics SVPs Engage In Heavy Transactions [Yahoo! Finance]
Low
Report
Celldex Therapeutics SVPs Engage In Heavy Transactions [Yahoo! Finance]
12/21
10:19 am
cldx
Barclays Lifts PT on Celldex Therapeutics (CLDX) to $24 From $21 [Yahoo! Finance]
Medium
Report
Barclays Lifts PT on Celldex Therapeutics (CLDX) to $24 From $21 [Yahoo! Finance]
12/21
09:01 am
cldx
We're Hopeful That Celldex Therapeutics (NASDAQ:CLDX) Will Use Its Cash Wisely [Yahoo! Finance]
Medium
Report
We're Hopeful That Celldex Therapeutics (NASDAQ:CLDX) Will Use Its Cash Wisely [Yahoo! Finance]
12/17
12:40 pm
cldx
Celldex Therapeutics (NASDAQ:CLDX) had its price target raised by analysts at Barclays PLC from $21.00 to $24.00. They now have an "underweight" rating on the stock.
Medium
Report
Celldex Therapeutics (NASDAQ:CLDX) had its price target raised by analysts at Barclays PLC from $21.00 to $24.00. They now have an "underweight" rating on the stock.
12/9
08:01 am
cldx
Celldex Initiates Global Registrational Phase 3 Program of Barzolvolimab in Cold Urticaria and Symptomatic Dermographism
Medium
Report
Celldex Initiates Global Registrational Phase 3 Program of Barzolvolimab in Cold Urticaria and Symptomatic Dermographism